Skip to main navigation
Skip to search
Skip to main content
Arizona Board of Regents Home
Search content at Arizona Board of Regents
Home
Profiles
Departments and Centers
Scholarly Works
Grants
Activities
Equipment
Datasets
Press/Media
Prizes
SU‐GG‐T‐37: Dosimetric Comparison of Cs‐131 to I‐125 for Treatment of Occular Melenoma
A. Maurizo
, C. Watchman
Radiation Oncology
Research output
:
Contribution to journal
›
Article
›
peer-review
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'SU‐GG‐T‐37: Dosimetric Comparison of Cs‐131 to I‐125 for Treatment of Occular Melenoma'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Prescribed Dose
100%
Tumor
100%
Treatment Duration
100%
Dosimetric
100%
Occular
100%
Source Strength
100%
Risk Structure
100%
Dose Increase
100%
Dosimetric Comparison
100%
Ocular Melanoma
100%
Dosimetry
50%
Prescription Drugs
50%
Inpatient Treatment
50%
Dose-ranging
50%
Reduced Dose
50%
Brachytherapy
50%
Equivalent Dose
50%
Previously Treated Patients
50%
TG-43
50%
Air Kerma Strength
50%
Eye Plaque
50%
Biological Equivalent Dose
50%
Treatment Planning Software
50%
Medicine and Dentistry
Neoplasm
100%
Iodine 125
100%
Equivalent Dose
100%
Eye Melanoma
100%
Drug Dose Increase
100%
Treatment Planning
50%
Dosimetry
50%
Brachytherapy
50%
Mathematics
Treatment Time
100%
Treated Patient
50%